• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human HEPACAM family member 2 (HEPACAM2), Truncated

ACP06418

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP06418 Target NameHEPACAM2
Target SynonymsHEPACAM2; MIKI; UNQ305/PRO346; HEPACAM family member 2; Mitotic kinetics regulatorFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDA8MVW5
Background Information
  • Uniprot Id

    A8MVW5

  • Target Species

    Human

  • Target Name

    HEPACAM2

  • Target Full Name

    HEPACAM family member 2

  • Target Function

    Required during prometaphase for centrosome maturation. Following poly-ADP-ribosylation (PARsylation) by TNKS, translocates from the Golgi apparatus to mitotic centrosomes and plays a key role in the formation of robust microtubules for prompt movement of chromosomes: anchors AKAP9/CG-NAP, a scaffold protein of the gamma-tubulin ring complex and promotes centrosome maturation.

  • Target Subcellular Location

    Golgi apparatus membrane; Single-pass type I membrane protein. Cytoplasm, cytoskeleton, spindle. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Midbody.

  • Target Tissue Specificity

    Widely expressed.

  • Target Synonyms

    HEPACAM2; MIKI; UNQ305/PRO346; HEPACAM family member 2; Mitotic kinetics regulator

Inquire Recombinant Human HEPACAM family member 2 (HEPACAM2), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification